These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9728575)

  • 1. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes.
    Chart H; Jenkins C; Smith HR; Rowe B
    J Infect Dis; 1998 Sep; 178(3):920-1. PubMed ID: 9728575
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides by patients infected with strains of enterohaemorrhagic E. coli.
    Chart H; Cheasty T; Willshaw GA
    J Med Microbiol; 2002 Dec; 51(12):1050-1054. PubMed ID: 12466402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes.
    Bitzan M; Ludwig K
    J Infect Dis; 1998 Nov; 178(5):1551-2. PubMed ID: 9780291
    [No Abstract]   [Full Text] [Related]  

  • 4. The lipopolysaccharide core type of Escherichia coli O157:H7 and other non-O157 verotoxin-producing E. coli.
    Currie CG; Poxton IR
    FEMS Immunol Med Microbiol; 1999 May; 24(1):57-62. PubMed ID: 10340713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
    Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
    Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to lipopolysaccharides of Escherichia coli serogroups O5 and O165 in healthy adults.
    Jenkins C; Chart H
    Lancet; 1999 Aug; 354(9179):649-50. PubMed ID: 10466672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults.
    Zapata-Quintanilla LB; Palmeira P; Tino-De-Franco M; Amaral JA; Carbonare CB; Carbonare SB
    Scand J Immunol; 2006 Dec; 64(6):661-7. PubMed ID: 17083623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of tccP in clinical enterohemorrhagic and enteropathogenic Escherichia coli isolates.
    Garmendia J; Ren Z; Tennant S; Midolli Viera MA; Chong Y; Whale A; Azzopardi K; Dahan S; Sircili MP; Franzolin MR; Trabulsi LR; Phillips A; Gomes TA; Xu J; Robins-Browne R; Frankel G
    J Clin Microbiol; 2005 Nov; 43(11):5715-20. PubMed ID: 16272509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli O157 serology: false-positive ELISA results caused by human antibodies binding to bovine serum albumin.
    Chart H; Evans J; Chalmers RM; Salmon RL
    Lett Appl Microbiol; 1998 Aug; 27(2):76-8. PubMed ID: 9750326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary antibodies to lipopolysaccharide antigens of Escherichia coli O157.
    Chart H; Jenkins C
    Lancet; 1998 Aug; 352(9125):371. PubMed ID: 9717931
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and evaluation of latex agglutination tests for the detection of human antibodies to the lipopolysaccharides of verocytotoxin-producing Escherichia coli (VTEC) serogroups O157 and non-O157.
    Rastawicki W; Chróst A; Gielarowiec K
    J Microbiol Methods; 2017 Sep; 140():74-76. PubMed ID: 28732694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.
    Navarro A; Eslava C; Hernandez U; Navarro-Henze JL; Aviles M; Garcia-de la Torre G; Cravioto A
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):797-801. PubMed ID: 12965907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of usefulness of the enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to lipopolysaccharides of Enterohemorrhagic Escherichia coli (EHEC) strains in patients with gastrointestinal disorders and patients with hemolytic uremic syndrome].
    Med Dosw Mikrobiol; 2014; 66(3-4):161-75. PubMed ID: 25804070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of lipopolysaccharide by strains of Shigella dysenteriae, Shigella flexneri and Shigella boydii and their cross-reacting strains of Escherichia coli.
    Chart H; Daniel RM; Cheasty T
    FEMS Microbiol Lett; 2009 Mar; 292(1):21-6. PubMed ID: 19222579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic relatedness of a non-motile variant O157 enteropathogenic Escherichia coli (EPEC) strain and E. coli strains belonging to pathogenic related groups.
    Regua-Mangia AH; Andrade JR; Gonzalez AG; Zahner V; Cerqueira AM; Teixeira LM
    Microbiol Res; 2008; 163(2):225-33. PubMed ID: 16815695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157.
    Braoudaki M; Hilton AC
    FEMS Microbiol Lett; 2004 Jun; 235(2):305-9. PubMed ID: 15183878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophoretic and immunochemical study of the lipopolysaccharides produced by chemostat-grown Escherichia coli O157.
    Dodds KL; Perry MB; McDonald IJ
    J Gen Microbiol; 1987 Sep; 133(9):2679-87. PubMed ID: 2452229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Thijs LG; MacLaren DM
    J Infect Dis; 1986 Sep; 154(3):538-9. PubMed ID: 3525700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.